Marcellusi, A. (2023) “[Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]”, Farmeconomia. Health economics and therapeutic pathways, 24(1). doi: 10.7175/fe.v24i1.1548.